Published in Neoplasma on January 01, 1979
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide. Eur J Nucl Med (1994) 2.05
Dopachrome tautomerase is not essential for DHICA formation. Pigment Cell Res (1994) 2.03
Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res (1998) 1.40
Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol (1994) 1.39
The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007. J Perinatol (2009) 1.36
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet (2001) 1.23
Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J Biol Chem (1997) 1.21
Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study. Age Ageing (2010) 1.11
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06
Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol (2001) 1.05
Large-scale cultivation of human melanocytes using collagen-coated Sephadex beads (cytodex 3). J Invest Dermatol (1989) 1.03
Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells. Melanoma Res (1992) 1.02
Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori (1980) 1.01
(Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes. J Invest Dermatol (1998) 1.00
Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry. J Cancer Res Clin Oncol (1983) 0.98
SPRR4, a novel cornified envelope precursor: UV-dependent epidermal expression and selective incorporation into fragile envelopes. J Cell Sci (2001) 0.94
Solar-simulated skin adaptation and its effect on subsequent UV-induced epidermal DNA damage. J Invest Dermatol (2001) 0.93
[On the classification and nomenclature of hyperplasia of laryngeal squamous epithelium]. Z Laryngol Rhinol Otol (1967) 0.91
Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report. Cancer Detect Prev (1983) 0.91
A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma. Tumori (1981) 0.90
Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline. Neth J Med (2007) 0.89
Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford) (2004) 0.87
UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis (2001) 0.86
A new possible pathogenesis of some gallstones. Med Hypotheses (1984) 0.86
DNA content and MHC class II antigen expression in malignant melanoma: clinical course. J Clin Pathol (1988) 0.86
Digital dermatoscopic follow-up of 1027 melanocytic lesions in 121 patients at risk of malignant melanoma. J Eur Acad Dermatol Venereol (2012) 0.85
Evidence for the presence of lysine vasotocin in the pig pineal gland. Endocrinology (1965) 0.85
[Pachydermia laryngitis and smoking]. Z Laryngol Rhinol Otol (1972) 0.85
Melanin content of cultured human melanocytes and UV-induced cytotoxicity. J Photochem Photobiol B (2001) 0.83
Serum alkaline-stable acid thiol proteinase--a possible marker for primary liver carcinoma. Neoplasma (1984) 0.83
The combined effects of extracts containing carotenoids and vitamins E and C on growth and pigmentation of cultured human melanocytes. Skin Pharmacol Physiol (2004) 0.83
Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal Biochem (1990) 0.83
Cutaneous side-effects of transdermal iontophoresis with and without surfactant pretreatment: a single-blinded, randomized controlled trial. Br J Dermatol (2005) 0.82
Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus. Lupus (2007) 0.82
Melanin-related metabolites as markers of the skin pigmentary system. J Invest Dermatol (1987) 0.81
CAP (cyclophosphamide, adriamycin, cisplatinum) in the treatment of advanced breast cancer. Neoplasma (1984) 0.81
Variations in melanin formation by cultured melanocytes from different skin types. Arch Dermatol Res (1998) 0.81
Light therapy (with UVA-1) for SLE patients: is it a good or bad idea? Rheumatology (Oxford) (2006) 0.81
Characterization of cathepsin B-like proteinase from ascitic fluid of patients with primary liver cancer. Neoplasma (1984) 0.80
Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine. J Invest Dermatol (1997) 0.80
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). Med Oncol Tumor Pharmacother (1990) 0.80
Comet assay demonstrates a higher ultraviolet B sensitivity to DNA damage in dysplastic nevus cells than in common melanocytic nevus cells and foreskin melanocytes. J Invest Dermatol (1996) 0.80
Treatment results of the thioether lipid ilmofosine in patients with malignant tumours. J Cancer Res Clin Oncol (1992) 0.79
Intralesional BCG application in malignant melanoma. Neoplasma (1976) 0.79
Comparison of lipids between tumor and normal hamster melanosomes. Neoplasma (1983) 0.79
Phase II clinical evaluation of etoposide (VP-16-213, Vepesid) as a second-line treatment in ovarian cancer. Results of the South-East European Oncology Group (SEEOG) Study. Oncology (1990) 0.79
Prognostic significance of c-erbB-2 gene expression in pancreatic cancer patients. Neoplasma (2001) 0.79
Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol (2001) 0.79
Simple screening test for estimation of some phenolic and indolic compounds in urine application to melanoma. J Invest Dermatol (1978) 0.79
Retracted [Usefulness of micronutrients in the treatment of periodontitis]. Ned Tijdschr Tandheelkd (2010) 0.79
A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol (2003) 0.79
Analysis of eumelanin-related indolic compounds in urine by high-performance liquid chromatography with fluorimetric detection. J Chromatogr (1986) 0.79
Distribution of zinc and copper in pigmented tissues. Hoppe Seylers Z Physiol Chem (1973) 0.79
Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology (2002) 0.79
[Non-cutaneous manifestations of secondary syphilis]. Ann Dermatol Venereol (2008) 0.78
[Chemical composition of melanosomes]. Dermatol Monatsschr (1970) 0.78
Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer. Neoplasma (2004) 0.78
[Chemistry and biochemistry of melanin]. Dermatol Monatsschr (1970) 0.78
Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase. Biochem Pharmacol (1995) 0.78
Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption. Br J Dermatol (2005) 0.78
Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption. Exp Dermatol (2008) 0.78
Presence of relatively high concentrations of arginine vasotocin in the cerebrospinal fluid of newborns and infants. J Clin Endocrinol Metab (1980) 0.78
Preparation of monoclonal mouse antibodies against two specific eu-melanin related compounds. J Immunol Methods (1992) 0.78
Catechol-O-methyltransferase in vitiligo. Arch Dermatol Res (1994) 0.78
Vasotocin content in the pineal gland of foetal, newborn and adult male rats. J Endocrinol (1975) 0.78
A GABAergic habenulo-raphe pathway mediates both serotoninergic and hypnogenic effects of vasotocin in cats. Brain Res Bull (1984) 0.78
[Anakinra treatment in Schnitzler syndrome - results of the first retrospective multicenter study in six patients from the Czech Republic]. Klin Onkol (2014) 0.77
A spectrophotometric assay for mammalian tyrosinase utilizing the formation of melanochrome from L-dopa. Anal Biochem (1985) 0.77
Effect of topical tretinoin under occlusion on atypical naevi. Melanoma Res (1998) 0.77
Vasotocin biosynthesis by neurohypophysial cells from human fetuses. Evidence for its ependymal origin. Neuroendocrinology (1975) 0.77
Do some malignant melanoma cells share antigens with the myeloid monocyte lineage? Neoplasma (1991) 0.77
Differences in subcellular distribution of catechol-O-methyltransferase and tyrosinase in malignant melanoma. J Invest Dermatol (1993) 0.77
O-methylation of L-dopa in melanin metabolism and the presence of catechol-O-methyltransferase in melanocytes. Pigment Cell Res (1994) 0.77
REM sleep suppression in cats by melatonin. Brain Res Bull (1981) 0.77
Vasotocin, melatonin and narcolepsy: possible involvement of the pineal gland in its patho-physiological mechanism. Peptides (1980) 0.77
Detection and differentiation of causative organisms of onychomycosis in an ex vivo nail model by means of Raman spectroscopy. J Eur Acad Dermatol Venereol (2013) 0.77
Cytotoxic interactions of Zn2+ in vitro: melanoma cells are more susceptible than melanocytes. Melanoma Res (1997) 0.77
Subcellular fractionation of cultured normal human melanocytes: new insights into the relationship of melanosomes with lysosomes and peroxisomes. Biochim Biophys Acta (1993) 0.77
Photoisomerization spectrum of urocanic acid in human skin and in vitro: effects of simulated solar and artificial ultraviolet radiation. Br J Dermatol (1995) 0.77
Melanogenesis in transfected fibroblasts induces lysosomal activation. Arch Dermatol Res (1997) 0.77
The hair melanosome: another tissue reservoir of zinc. Physiol Bohemoslov (1976) 0.77
Prolonged increase of cis-urocanic acid levels in human skin and urine after single total-body ultraviolet exposures. Photochem Photobiol (1997) 0.77
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study. Oncology (1987) 0.77
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors. Neoplasma (1977) 0.76
Melanosome: an unusually resistant subcellular particle. Cell Biol Int Rep (1977) 0.76
Increased anthralin irritation response in vitiliginous skin. Arch Dermatol Res (1989) 0.76
Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro. Clin Exp Immunol (2006) 0.76
Slow-wave sleep induced in cats by extremely small amounts of synthetic and pineal vasotocin injected into the third ventricle of the brain. Brain Res Bull (1977) 0.76
[Detection and occurrence of BRCA 1 gene mutation in patients with carcinoma of the breast and ovary]. Ceska Gynekol (2003) 0.76
[Distribution of zinc and copper in different-colored human hair]. Dermatol Monatsschr (1973) 0.76